The effect of dabigatran in patients suffering myocardial injury after non-cardiac surgery - ACC 2018,

An expert peer-to-peer discussion on the latest data to come out of the MANAGE trial and its implications for clinical practice.







Sunday 11th March 2018 @ 11:45 EST ACC.18 Congress, Orlando, FL Discussants: Dr PJ Devereaux (Ontario, US) & Dr John Eikelboom (Ontario, US) Dr PJ Devereaux, Director of Cardiology, McMaster University, Ontario The focus of Prof Devereux’s clinic research is vascular complications around the time of surgery. He is undertaking several large international RCTs and observational studies addressing this issue. He has published more than 250 peer reviewed papers and over 50 book chapters and editorials. Dr John Eikelboom, Associate Professor, Division of Hematology & Thromboembolism, McMaster University, Ontario Dr Eikelboom’s current research focuses on variable response to antiplatelet therapy, antithrombotic therapy in atrial fibrillation, and mechanisms and prognosis of bleeding. He has published more than 150 peer-reviewed papers. This discussion was funded by an unrestricted educational grant by Boehringer Ingelheim